Page last updated: 2024-10-31

molsidomine and Cancer of Prostate

molsidomine has been researched along with Cancer of Prostate in 2 studies

Molsidomine: A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.
molsidomine : A member of the class of oxadiazoles that is 1,2,3-oxadiazole substituted by morpholin-4-yl and (ethoxycarbonyl)azanidyl groups at positions 3 and 5, respectively. It is used as a vasodilator drug for the treatment of myocardial ischemic syndrome and congestive heart failure.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Patra, N1
De, U1
Kang, JA1
Kim, JM1
Ahn, MY1
Lee, J1
Jung, JH1
Chung, HY1
Moon, HR1
Kim, HS1
Juang, HH1

Other Studies

2 other studies available for molsidomine and Cancer of Prostate

ArticleYear
A novel epoxypropoxy flavonoid derivative and topoisomerase II inhibitor, MHY336, induces apoptosis in prostate cancer cells.
    European journal of pharmacology, 2011, May-11, Volume: 658, Issue:2-3

    Topics: Antineoplastic Agents; Apoptosis; Biocatalysis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; DN

2011
Nitroprusside stimulates mitochondrial aconitase gene expression through the cyclic adenosine 3',5'-monosphosphate signal transduction pathway in human prostate carcinoma cells.
    The Prostate, 2004, Sep-15, Volume: 61, Issue:1

    Topics: Aconitate Hydratase; Ascorbic Acid; Blotting, Western; Cell Line, Tumor; Cyclic AMP; Free Radical Sc

2004